Protagenic Therapeutics, Inc. (PTIX)
1.026
-0.03
(-3.22%)
USD |
OTCM |
Sep 08, 16:00
Protagenic Therapeutics Market Cap : 1.857M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.857M |
| September 04, 2026 | 1.919M |
| September 03, 2026 | 1.810M |
| September 02, 2026 | 1.901M |
| September 01, 2026 | 2.154M |
| August 31, 2026 | 2.172M |
| August 28, 2026 | 1.774M |
| August 27, 2026 | 1.693M |
| August 26, 2026 | 1.611M |
| August 25, 2026 | 1.720M |
| August 24, 2026 | 1.973M |
| August 21, 2026 | 1.450M |
| August 20, 2026 | 1.086M |
| August 19, 2026 | 0.6336M |
| August 18, 2026 | 0.6517M |
| August 17, 2026 | 0.6517M |
| August 14, 2026 | 0.6517M |
| August 13, 2026 | 0.6517M |
| August 12, 2026 | 0.6517M |
| August 11, 2026 | 0.6192M |
| August 10, 2026 | 0.6772M |
| August 07, 2026 | 0.5989M |
| August 06, 2026 | 0.4257M |
| August 05, 2026 | 0.5008M |
| August 04, 2026 | 0.4063M |
| Date | Value |
|---|---|
| August 03, 2026 | 0.3548M |
| July 31, 2026 | 0.3483M |
| July 30, 2026 | 0.3224M |
| July 29, 2026 | 0.2481M |
| July 28, 2026 | 0.2709M |
| July 27, 2026 | 0.4245M |
| July 24, 2026 | 0.4172M |
| July 23, 2026 | 0.4172M |
| July 22, 2026 | 0.4172M |
| July 21, 2026 | 0.4172M |
| July 20, 2026 | 0.5037M |
| July 17, 2026 | 0.5037M |
| July 16, 2026 | 0.5037M |
| July 15, 2026 | 0.5037M |
| July 14, 2026 | 0.5037M |
| July 13, 2026 | 0.5037M |
| July 10, 2026 | 0.5031M |
| July 09, 2026 | 0.4257M |
| July 08, 2026 | 0.3676M |
| July 07, 2026 | 0.387M |
| July 06, 2026 | 0.4294M |
| July 02, 2026 | 0.445M |
| July 01, 2026 | 0.6772M |
| June 30, 2026 | 0.7587M |
| June 29, 2026 | 0.7587M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.84B |
| Oncolytics Biotech, Inc. | 100.33M |
| Sangamo Therapeutics, Inc. | 66.66M |
| Sarepta Therapeutics, Inc. | 2.349B |
| Anixa Biosciences, Inc. | 95.66M |
Market Cap Related Metrics
| PE Ratio | 0.3479 |
| Price to Book Value | 1.078 |
| Price | 1.026 |
| Earnings Yield | 287.4% |
| Normalized PE Ratio | 0.4987 |